Black Diamond Therapeutics shares owned by Citigroup
Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Black Diamond Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Black Diamond Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Black Diamond Therapeutics by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $126k | 29k | 4.36 |
| 2024-06-30 | $38k | 8.2k | 4.66 |
| 2024-03-31 | $570k | 113k | 5.07 |
| 2023-12-31 | $152k | 54k | 2.81 |
| 2023-09-30 | $176k | 61k | 2.87 |
| 2022-12-31 | $243 | 135 | 1.80 |
| 2022-09-30 | $999 | 573 | 1.75 |
| 2021-12-31 | $37k | 6.9k | 5.37 |
| 2021-03-31 | $3.2M | 128k | 24.96 |
| 2020-12-31 | $235k | 7.5k | 31.44 |
| 2020-09-30 | $89k | 2.9k | 31.25 |
| 2020-06-30 | $165k | 4.0k | 41.47 |
| 2020-03-31 | $88k | 3.5k | 24.88 |